منابع مشابه
Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers
OBJECTIVE To identify an early response criterion for predicting ≥5% weight loss with liraglutide 3.0 mg at week 56 and to compare efficacy outcomes in early responders (ERs) and early nonresponders (ENRs). METHODS Using pooled data from the SCALE Obesity and Prediabetes and SCALE Diabetes trials, weight loss of ≥4% at 16 weeks best predicted ≥5% weight loss after 56 weeks. Weight loss and ch...
متن کاملProstaglandins: a report on early clinical studies.
The prostaglandins are a unique group of pharmacologically active lipids which are widely distributed in mammalian tissues and body fluids. The chemistry of this family of compounds has been established in elegant detail. Research quantities of these highly active natural compounds were obtained by enzymatic bioconversion of essential fatty acids and now studies devoted to the elucidation of th...
متن کاملترجمه کتاب با مقدمه و تحقیق (studies in early christology) مطالعاتی در مسیح شناسی متقدم
مارتین هنگل ،نویسنده کتاب حاضر- مطالعاتی درمسیحیت شناسی اولیه- بااستفاده ازاسنادتاریخی ونظریات مستندمنتقدین عهدجدید،که خودمسیحی بوده اند،دربیان مفاهیمی همچون موعود بودن ،تصلیب ،رستاخیزی،پسرانسان،اناجیل ودرمعرفی حواریون حضرت،اظهار داشته است که احتمالانگارش انجیل تحت تاثیرتفکرات یهودی-هلنیستی می باشد. نویسنده کتاب تنهاانجیل مرقس رامعتبرمی داند. این کتاب که شامل هفت بخش( 1)عیسی ،موعوداسراییل.2)ع...
15 صفحه اولLiraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
STUDY QUESTION What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections? METHODS The study was a randomised, double blind, placebo controlled trial with a parallel group design carried out at 13 hospital based outpatient clinics and one primary care unit in Sweden. Patients were conside...
متن کاملCancer therapy with phytochemicals: evidence from clinical studies
Cancer is still one of the major causes of mortality in both developing and developed countries. At this time, in spite of intensive interventions, a large number of patients have poor prognosis. Therefore, the effort for finding new anticancer agents with better efficacy and lesser side effects has continued. According to the traditional recommendations and experimental studies, numerous medic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Clinical Practice
سال: 2010
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2010.02500.x